Skip to main content
60°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angiodynamics Inc
(NQ:
ANGO
)
7.680
+0.170 (+2.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Angiodynamics Inc
< Previous
1
2
3
4
5
6
7
Next >
ANGO Stock Earnings: AngioDynamics Beats EPS, Misses Revenue for Q2 2024
January 05, 2024
ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today?
January 05, 2024
AngioDynamics Inc (NASDAQ: ANGO) has reported a second-quarter (Q2) FY24 adjusted EPS loss of $(0.05), compared to the consensus of $(0.07) and EPS income of
Via
Benzinga
US Stocks Poised To Extend New Year Slump As Focus Shifts To December Jobs Data: Analyst Sees S&P Testing 4,800 On This Condition
January 05, 2024
Important metrics to track include the flow of individuals entering the labor force and the ratio of part-time workers to full-timers.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
January 05, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Investor Sentiment Edges Lower Ahead Of Jobs Report; Nasdaq Tumbles For 5th Consecutive Day
January 05, 2024
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, with the index moving to the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, with the Nasdaq...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Preview For AngioDynamics
January 04, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About AngioDynamics
October 05, 2023
Via
Benzinga
Costco Wholesale, Constellation Brands And 3 Stocks To Watch Heading Into Friday
January 05, 2024
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Earnings Scheduled For January 5, 2024
January 05, 2024
Companies Reporting Before The Bell • Constellation Brands (NYSE:STZ) is estimated to report quarterly earnings at $3.00 per share on revenue of $2.54 billion.
Via
Benzinga
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
December 21, 2023
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
December 07, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Why Angiodynamics Stock Sank Today
October 04, 2023
The company didn't get investors excited about its latest set of quarterly figures.
Via
The Motley Fool
Preview: AngioDynamics's Earnings
October 03, 2023
Via
Benzinga
Why AngioDynamics Stock Popped on Monday
September 25, 2023
AngioDynamics has fascinating technology, but few prospects for profits.
Via
The Motley Fool
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
December 07, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Constellation Brands To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Friday
October 06, 2023
HSBC raised the price target for Constellation Brands, Inc. (NYSE: STZ) from $280 to $290. HSBC analyst Carlos Laboy maintained a Buy rating. Constellation shares fell 3.2% to close at $241.33 on...
Via
Benzinga
Medical Devices Player AngioDynamics Exceeds Q1 Expectations, Sticks To Annual Guidance
October 04, 2023
AngioDynamics Inc (NASDAQ: ANGO) has reported a Q1 FY24 adjusted EPS loss of $(0.12), beating the consensus of $(0.13) but higher than $(0.06) reported a year ago.
Via
Benzinga
S&P 500, Nasdaq Face Uphill Battle As Bond Yields Rise; Analyst Pins Hope On Key Jobs Data This Week
October 04, 2023
Stock futures point to a nervous start yet again on Wednesday as the 10-year T-note set a fresh 16-year high.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
October 04, 2023
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics - Undervalued Gem In Med Tech: Analyst Eyes Stellar Growth With A 'Buy' Stance
September 25, 2023
H.C. Wainwright initiated coverage on AngioDynamics Inc (NASDAQ: ANGO), noting that the company is debt-free and significantly undervalued compared to peers in a growing market.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
September 12, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
September 02, 2023
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Performance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On Wednesday
August 16, 2023
U.S. stocks traded mixed, with the Dow Jones gaining close to 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
August 15, 2023
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
August 03, 2023
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
July 31, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Should Growth Investors Buy This Revolutionary Small-Cap Stock?
July 25, 2023
The medical devices company is taking an exciting approach to treating some of the most complex diseases.
Via
The Motley Fool
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
July 24, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Why Are AngioDynamics Shares Trading Lower Today
July 12, 2023
AngioDynamics Inc (NASDAQ: ANGO) has reported a Q4 FY23 adjusted EPS of $0.02, in line with the consensus EPS higher than $0.01 a year ago.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.